Iwona Solarska

FLT3-ITD and MLL-PTD influence the expression of MDR-1, MRP-1, and BCRP mRNA but not LRP mRNA assessed with RQ-PCR method in adult acute myeloid leukemia

Barbara Nasiłowska‐Adamska, Iwona Solarska, Monika Paluszewska et al. · Annals of Hematology · 2013 · 20 citations

Hematological Malignancy, Tumor Biology, Bcrp Mrna +13

Complete cytogenetic and molecular response after imatinib treatment for chronic myeloid leukemia in a patient with atypical karyotype and BCR-ABL b2a3 transcript

Barbara Pieńkowska‐Grela, Renata Woroniecka, Iwona Solarska et al. · Cancer Genetics and Cytogenetics · 2007 · 18 citations

Hematological Malignancy, Chronic Myeloid Leukemia, Medicine +10

Frequency of BCR‑ABL gene mutations in Polish patients with chronic myeloid leukemia treated with imatinib. A final report of the MAPTEST study

Krzysztof Lewandowski, Krzysztof Warzocha, Andrzej Hellmann et al. · Polskie Archiwum Medycyny Wewnętrznej · 2009 · 16 citations · Full text

Circulating T Cells of Patients with Nijmegen Breakage Syndrome Show Signs of Senescence

Ruud W. J. Meijers, Katarzyna Dzierżanowska‐Fangrat, Magdalena Zborowska et al. · Journal of Clinical Immunology · 2016 · 14 citations · Full text

Autoimmune Disease, T Cells, Hematology +8

IDH2 mutations in patients with normal karyotype AML predict favorable responses to daunorubicin, cytarabine and cladribine regimen

Marta Libura, Emilia Białopiotrowicz, Sebastian Giebel et al. · Scientific Reports · 2021 · 11 citations · Full text